BIOMAT Database Logo BIOMAT Database Logo

An appraisal of current systemic chemotherapy for psoriasis. 1976

E M Farber, and D Pearlman, and E A Abel

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008727 Methotrexate An antineoplastic antimetabolite with immunosuppressant properties. It is an inhibitor of TETRAHYDROFOLATE DEHYDROGENASE and prevents the formation of tetrahydrofolate, necessary for synthesis of thymidylate, an essential component of DNA. Amethopterin,Methotrexate Hydrate,Methotrexate Sodium,Methotrexate, (D)-Isomer,Methotrexate, (DL)-Isomer,Methotrexate, Dicesium Salt,Methotrexate, Disodium Salt,Methotrexate, Sodium Salt,Mexate,Dicesium Salt Methotrexate,Hydrate, Methotrexate,Sodium, Methotrexate
D008730 Methoxsalen A naturally occurring furocoumarin compound found in several species of plants, including Psoralea corylifolia. It is a photoactive substance that forms DNA ADDUCTS in the presence of ultraviolet A irradiation. 8-Methoxypsoralen,Ammoidin,Xanthotoxin,8-MOP,Deltasoralen,Dermox,Geroxalen,Meladinina,Meladinine,Meloxine,Methoxa-Dome,Méladinine,Oxsoralen,Oxsoralen-Ultra,Puvalen,Ultramop,8 MOP,8 Methoxypsoralen,8MOP,Methoxa Dome,Oxsoralen Ultra
D009173 Mycophenolic Acid Compound derived from Penicillium stoloniferum and related species. It blocks de novo biosynthesis of purine nucleotides by inhibition of the enzyme inosine monophosphate dehydrogenase (IMP DEHYDROGENASE). Mycophenolic acid exerts selective effects on the immune system in which it prevents the proliferation of T-CELLS, LYMPHOCYTES, and the formation of antibodies from B-CELLS. It may also inhibit recruitment of LEUKOCYTES to sites of INFLAMMATION. Cellcept,Mycophenolate Mofetil,Mycophenolate Mofetil Hydrochloride,Mycophenolate Sodium,Mycophenolic Acid Morpholinoethyl Ester,Myfortic,RS 61443,RS-61443,Sodium Mycophenolate,Mofetil Hydrochloride, Mycophenolate,Mofetil, Mycophenolate,Mycophenolate, Sodium,RS61443
D011565 Psoriasis A common genetically determined, chronic, inflammatory skin disease characterized by rounded erythematous, dry, scaling patches. The lesions have a predilection for nails, scalp, genitalia, extensor surfaces, and the lumbosacral region. Accelerated epidermopoiesis is considered to be the fundamental pathologic feature in psoriasis. Palmoplantaris Pustulosis,Pustular Psoriasis of Palms and Soles,Pustulosis Palmaris et Plantaris,Pustulosis of Palms and Soles,Psoriases
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006918 Hydroxyurea An antineoplastic agent that inhibits DNA synthesis through the inhibition of ribonucleoside diphosphate reductase. Hydroxycarbamid,Hydrea,Oncocarbide
D000477 Alkylating Agents Highly reactive chemicals that introduce alkyl radicals into biologically active molecules and thereby prevent their proper functioning. Many are used as antineoplastic agents, but most are very toxic, with carcinogenic, mutagenic, teratogenic, and immunosuppressant actions. They have also been used as components in poison gases. Alkylating Agent,Alkylator,Alkylators,Agent, Alkylating,Agents, Alkylating

Related Publications

E M Farber, and D Pearlman, and E A Abel
Systemic chemotherapy for psoriasis: a national survey.
July 1976, Archives of dermatology,
E M Farber, and D Pearlman, and E A Abel
Enzyme kinetics and combination chemotherapy: an appraisal of current concepts.
January 1975, Advances in enzyme regulation,
E M Farber, and D Pearlman, and E A Abel
[Histological appraisal of systemic treatment of psoriasis with hydroxyurea].
January 1976, Przeglad dermatologiczny,
E M Farber, and D Pearlman, and E A Abel
Safety of current systemic therapies for nail psoriasis.
January 2023, Expert opinion on drug safety,
E M Farber, and D Pearlman, and E A Abel
Current and future oral systemic therapies for psoriasis.
January 2015, Dermatologic clinics,
E M Farber, and D Pearlman, and E A Abel
Current and emerging systemic treatment strategies for psoriasis.
October 2012, Drugs,
E M Farber, and D Pearlman, and E A Abel
Current systemic therapies for psoriasis: where are we now?
August 2003, Journal of the American Academy of Dermatology,
E M Farber, and D Pearlman, and E A Abel
Neoadjuvant Chemotherapy in Pancreatic Cancer: An Appraisal of the Current High-Level Evidence.
January 2021, Pharmacology,
E M Farber, and D Pearlman, and E A Abel
Chemotherapy of glioblastoma multiforme: an appraisal.
October 1966, Bulletin of the Los Angeles neurological societies,
E M Farber, and D Pearlman, and E A Abel
An appraisal of ultraviolet lamps used for the phototherapy of psoriasis.
July 1987, The British journal of dermatology,
Copied contents to your clipboard!